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ABSTRAK
Tujuan: mendeteksi mikrodelesi kromosom Y pada pria dengan azoospermia atau oligozoospermia berat 
menggunakan multipleks PCR. Metode: kami menggunakan 2 multipleks PCR untuk mengamplifikasi regio 
AZF pada 71 pria. Kriteria inklusi adalah pria azoospermia atau oligozoospermia berat, dengan atau tanpa 
kelainan motilitas atau morfologi sperma, FSH meningkat atau normal, LH dan testosteron normal, dan tidak 
ada tumor testis atau kelainan lainnya. Lima pria normal berpartisipasi sebagai kontrol. Hasil: delesi parsial 
AZFa ditemukan pada 11 pria (15,49%), delesi komplit AZFb pada 1 pria (1,4%), dan delesi komplit AZFc pada 
1 pria (1,4%). Tipe delesi tidak spesifik juga terdeteksi, yaitu delesi gen DBY pada 2 pria (2.81%), dan delesi 
parsial AZFa dan AZFb pada dua pria (2.81%). Pada pria kontrol tidak ditemukan delesi. Tipe delesi AZFa 
dan AZFb menunjukkan gangguan spermatogenesis pada sebagian tubulus, yaitu spermatogenesis berhenti 
pada fase spermatosit, sedangkan delesi gen DBY menunjukkan gambaran sel sertoli saja (SCO) pada semua 
tubulus. Kesimpulan: frekuensi delesi parsial AZFa relatif tinggi pada penelitian ini. Tipe delesi menunjukkan 
gambaran gangguan spermatogenesis yang berbeda pada histopatologi testis.
Kata kunci: azoospermia, infertilitas pria, mikrodelesi, multipleks polymerase chain reaction, kromosom Y.
ABSTRACT
Aim: to detect Y-chromosomal microdeletion in Indonesian men with azoospermia or severe oligozoospermia 
using multiplex PCR. Methods: we performed 2 multiplex PCR amplifications of the Azoospermia Factor (AZF) 
region in 71 men. Criteria for including a patient were fulfilled if they presented with azoospermia or severe 
oligozoospermia, with or without additional abnormalities of sperm motility or of head morphology, raised or 
normal levels of FSH, normal levels of LH and testosterone, and with no evidence of testicular tumors or other 
abnormalities. Five men participated as control persons. Results: partial deletion of AZFa was found in 11 men 
(15.49%), complete deletion of AZFb in 1 man (1.4%), and complete deletion of AZFc in 1 man (1.4%). The 
unspecific type of deletion was also detected, including the DBY gene in 2 men (2.81%), and partial deletion of 
both AZFa and AZFb in 2 men (2.81%). No AZF deletion was observed in the control probands. Related to the 
type of deletion, the AZFa and AZFb deletion showed spermatogenesis arrest in most tubules, while deletion of the 
DBY gene is associated with the sertoli cell only (SCO) syndrome. Conclusion: the frequency of partial deletion of 
AZFa was found to be relatively high in our center. The type of deletion is associated with the testicular histology.
Keywords: azoospermia, male infertility, microdeletion, multiplex polymerase chain reaction, Y chromosome.
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INTRODUCTION
Infertility is a major health problem that 
affects 10-15% of couples who are unable to 
have children. Infertility in men is known to be 
the cause of around 50% of these cases.1,2 One of 
the causes of infertility is azoospermia varying 
between 10-15% in infertile men.3
With the development of assisted reproductive 
techniques, especially intra cytoplasmic sperm 
injection (ICSI), infertile men may well have 
a chance to become a father. However, several 
current researches suggest that as many as 
10-15% of men with azoospermia or severe 
oligozoospermia have a genetic abnormality.4 
The two most common causes of genetic 
abnormality in infertile men are Klinefelter 
syndrome (47 XXY) and microdeletion of AZF 
region.5 Therefore, it is highly recommended that 
microdeletion analysis is performed in those men 
with azoospermia or severe oligozoospermia prior 
to the TESE/ICSI procedure. The examination 
covers the diagnosis, management and prognosis 
of symptoms.2,6
To date, Y-chromosomal microdeletion 
screening has been performed in azoospermic 
and severe oligozoospermic men with differing 
results.7-9 It has been proposed, however, 
that patients with microdeletion involving 
AZFa and b should not undergo the Testicular 
Sperm Extraction (TESE)/ICSI procedure. 
The microdeletion detection method was 
established some time ago, in 1990, presenting 
inconsistent results due to the widely differing 
sequences in the Y chromosome and the many 
homologous locations. Therefore, Simoni et 
al.8 published a paper on the analysis of Y 
chromosome microdeletion with appropriate 
internal control in standardized multiplex 
Polymerase Chain Reaction (PCR) format as 
the methodology advocated by the European 
Academy of Andrology (EAA)/European 
Molecular Genetics Quality Networks (EMQN).8
So far, microdeletion analysis is still 
uncommon and not routinely carried out as a 
diagnostic procedure in patients undergo TESE/
ICSI in Indonesia. Research has been conducted 
by Suryandari DA et al.10, who found that the 
frequency of microdeletions in Indonesian men 
with azoospermia was 5.7%. The prevalence is 
apparently less than the prevalence obtained from 
a number of similar studies performed in different 
countries (10-15%).8 This fact might be due to the 
difference of genetic backgrounds in Indonesia, 
as compared to other countries, including the 
genetic causes of azoospermia. Another possibility 
might be due to differences in the methodology 
used. Hence, we performed Y- chromosomal 
microdeletion screening based on the EAA/
EMQN method in idiopathic azoospermic or 
severe oligozoospermic patients presenting at our 
urologic clinic between 2010 and 2012.
METHODS
Seventy one patients from the Urologic Clinic 
of Cipto Mangunkusumo Hospital between April 
2010 and April 2011 were clinically evaluated 
and found to have azoospermia or severe 
oligozoospermia (≤5 million/ml). Consecutive 
sampling method was used for recruiting the 
patients. Each patient was questioned and 
examined for testicular volumes, varicoceles, 
potential epididymal or prostate abnormalities, 
potential testicular tumors, seminal analysis 
and hormonal profile. An informed consent was 
obtained from all patients after approval local 
ethics committee (132/PT02.FK/ETIK/2010).
Criteria for including a patient in this study 
were fulfilled if they presented with azoospermia 
or severe oligozoospermia, with or without 
additional abnormalities of sperm motility or 
of head morphology, raised or normal levels 
of FSH, normal levels of LH and testosterone, 
and with no evidence of testicular tumors or 
other abnormalities. This patient group was 
asked to present an analysis of the respective 
cytogenetic chromosomes in order to exclude 
chromosome abnormalities associated with 
infertility. Only 2 patients gave their consent to 
undergo cytogenetic analysis.
Five fertile males joined this study as normal 
control persons and 5 females as control persons 
for DNA contamination during the whole 
procedure. We randomly chose men of our clinic 
member who have normal sperm analysis and 
hormone parameter to be a fertile control. The 
mean age is 33 SD 4.2 years. The five fertile men 
and 5 females, from our clinic member, gave their 
consent to be part of the research.
Vol 49 • Number 1 • January 2017                                 Y-chromosomal microdeletion in idiopathic azoospermic
19
Genomic DNA Isolation from Blood Samples 
and Testicular Testis Biopsy
Genomic DNA was extracted from blood 
samples (3 ml) from all patients and control 
persons. Testicular testis biopsy was carried out 
following consent from those patients at the same 
time of TESE procedure in our clinic. The tissue 
samples of testicular biopsy was placed in a tube 
with Bouin’s solution and sent to Department 
of Biology Faculty of Medicine Universitas 
Indonesia for full report of spermatogenesis 
activity. This samples also placed in formalin 
solution 70% and sent to pathologic anatomical 
analysis for potential of tumors.
Multiplex PCR Assay for AZF Microdeletion 
and Interpretation
Two multiplex PCR reactions (A and B) 
were used to identify deletions in AZFa, b and 
c regions. Both multiplex reactions contained 5 
fragments, 3 fragments marking the AZF loci and 
2 fragments the ZFY and SRY gene sequence. 
ZFY and SRY genes were used as a control. 
Twenty five μL PCR reaction solution was made 
up of 5 μL KAPA 10x buffer (containing MgCl2 
15mM), 0.5 μL10mM dNTP, 0.1μL KAPA Taq 
Polymerase enzyme, 0.25 μL 10x primer mix (2 
μM each primer), 0.8 μL DNA samples, and H2O 
up to 25 μL. 10X Primer Mix A and B is made by 
mixing each primer according to the multiplex A 
and B. The primer mix solution was then stored 
at 4°C temperature. All primer sequences are 
according to Foresta C, et al.11
For DNA amplification, the process begins 
with the initial activation at a temperature of 
95°C for 2 minutes, followed by 35 cycles of 
denaturation (94°C) for 15 seconds, annealing at 
58°C for 30 seconds, the elongation phase at 72°C 
for 10 minutes, and ending with the elongation 
phase end 72°C for 2 minutes. The cooling process 
was performed at 4°C. The 7 mL reaction products 
were separated by 2.5% of agarose gel at 50 volt 
for 3.5 hours. The PCR machine condition is based 
on the recommendation of KAPA 2GTM Fast 
Hot Start Ready Mix cycling parameters, with 
annealing temperature modification.
RESULTS
Seventeen out of 71 patients had microdeletion 
in their Y chromosome (23.94%). The mean 
age of evaluated patients was 35.98 SD 6.12 
years. The partial deletion of AZFa is the most 
common type deletion (15.49%). The frequency 
of microdeletion is given in Table 1. The clinical 
characteristic of men with Y-chromosomal 
microdeletion is given in Table 2.
In the PCR reaction, partial deletion of AZFa 
is characterized by absence of one of the two 
Table 1. The frequency and types of observed Y 
chromosome microdeletion in AZF regions
Type of microdeletion Frequency, n (%)
Partial deletion of AZFa 11 (15.49)
Complete deletion of AZFb 1 (1.40)
Complete deletion of AZFc 1 (1.40)
Deletion of DBY gene 
exon 2
2 (2.81)
Partial deletion of AZFa 
and AZFb
2 (2.81)
Undetected microdeletion 54 (76)
Table 2. Clinical charateristics of men with Y-chromosomal microdeletions
ID Semen analysis
Hormones
Types of microdeletion Testicular histology
FSH LH T
RA Azoospermia 6.6 NA 3.8 Partial deletion of AZFa NA
ME Azoospermia 5.6 2.6 5.6 Partial deletion of AZFa NA
PU Azoospermia 8.2 6.2 6.1 Partial deletion of AZFa NA
RD Azoopspermia 15.2 NA 3.3 Partial deletion of AZFa MA
AP Severe oligospermia 4.4 4.5 4.3 Partial deletion of AZFa NA
MD Azoospermia 7.5 4.4 7.1 Partial deletion of AZFa NA
FN Azoospermia 18.2 NA 2.6 Partial deletion of AZFa MA
SY Azoospermia 10.5 4.3 2.9 Partial deletion of AZFa NA
LC Azoospermia 9.8 NA 3.0 Partial deletion of AZFa NA
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primers, sY84 and sY86 (Figure 1). Complete 
deletion of AZFb is characterized by the absence 
of both primers, sY127 and sY134 (Figure 
2).8 Complete deletion in the AZFc region is 
characterized by the absence of primers, sY255 
and sY254.
The unspecific types of deletion found in 
our study were the deletion of DBY gene exon 2 
(Figure 3) and partial deletion in both of AZFa 
and AZFb. This kind of deletion has not yet been 
reported. In partial deletion of AZFa and AZFb, 
PCR reaction of multiplex B showed absence 
of sY84 and sY134. In multiplex A, all primers 
amplified the AZFs region.
Test icular  Histology in  Males wi th 
Microdeletion
We analyzed the testicular histology of 2 
patients with partial deletion of AZFa, 1 patient 
with AZFb, and 1 patient with DBY gene exon 2. 
Patients with partial deletions of AZFa indicated 
divergent spermatogenesis activity between the 
tubules (Figure 4).
The testicular histology of patient with 
complete deletion of AZFb showed maturation 
arrest at the primary spermatocyte stage in all 
tubules (Figure 5 left). Patients with deletion 
of DBY gene exon 2 showed signs of SCO 
syndrome in the testicular histology (Figure 5 
Table 2. Clinical charateristics of men with Y-chromosomal microdeletions
ID Semen analysis
Hormones
Types of microdeletion Testicular histology
FSH LH T
DN Severe oligospermia 5.6 NA 3.2 Partial deletion of AZFa NA
TF Azoospermia 4.4 NA 4.5 Partial deletion of AZFa NA
WD Azoospermia 30.5 8.8 5.2 Deletion of DBY gene exon 2 SCO
HN Azoospermia 6.2 NA 6.8 Deletion of DBY gene exon 2 NA
AF Azoospermia 25.6 NA 1.5 Complete deletion of AZFc NA
YR Azoospermia 8.4 NA 4.4 Complete deletion of AZFb MA
HN Azoospermia 4.4 NA 4.8 Partial deletion of AZFa and AZFb NA
AP Azoospermia 79 9.1 6.4 Partial deletion of AZFa and AZFb NA
FSH=Follicle Stimulating Hormone (mIU/ml); LH=Leutenizing Hormone (mIU/ml);  MA= maturation arrest; NA= not 
available; SCO= Sertoli-cell only; T=Testosterone (ng/ml)
Figure 1. Identification of partial deletion of AZFa. Multiplex PCR B was performed to identify AZFa partial deletion. The 
absence of PCR fragment sY84 in patients’ samples (line A-E) showed AZFa deletion. W=Water, M=Male, F=Female, NS= 
Male Normal Sample, A-E= Patients.
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Figure 2. Identification of complete deletion of AZFb. The deletion was marked by the absence of sY127 and sY134 PCR 
fragments in sample Z. M=marker (Px174), W=water, NS=normal sample, F=female, X and Z= patient.
Figure 3. Identification of deletion of DBY gene. The deletion 
was marked by the absence of DBY gene exon 2 fragments 
in sample (arrow). M=marker, W=water, NS=normal sample, 
A=patient.
Figure 4. Testicular histology in patients with partial deletion 
of AZFa sequence. Shown is the divergent image of tubuli 
and sperm (indicated by the arrow).
Figure 5. Testicular histological examination. Patient with 
complete deletion of AZFb showed spermatogenesis arrest 
at spermatocyte phase (left panel). Patient with complete 
deletion of DBY gene showed sertoli cells only syndrome 
(right panel).
right). Patients with non-specific deletion had 
not yet presented with a testicular histology.
DISCUSSION
Based on our study, the frequency of partial 
deletion of AZFa is relatively high. According 
to many international publications, most types 
of deletions are AZFc and only infrequently 
seen in the AZFa region.8,12-16 In a study using 
the Indonesian population as probands, with 
different PCR method and primers, Suryandari 
DA, et al.10 found AZFa and AZFb deletion 
in 2.8% and AZFc deletion in 2.8% patients 
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(n=35).10 They used duplex PCR, not multiplex, 
and sY14(SRY), sY84 (AZFa), RBMY1 (AZFb), 
sY 254 and sY255 (AZFc) as primers.
Deletion of the AZFa region is rare in all 
populations (about 2% in men with impaired 
spermatogenesis).17 Therefore, it may be 
concluded that the literature, to date, presents 
very limited information on the AZFa region.
The possible explanation of high prevalence 
of partial AZFa microdeletion (sY84- absent, 
sY86-present) in our patients may be due to 
false positives of AZFa microdeletion caused 
by single-nucleotide polymorphism (SNP) as 
proposed by Qing Wu et al.18 They found that 
there were single-nucleotide alteration of T to G 
in the target sequence of the reverse sY84 primer 
(rs72609647). This SNP is more prevalent in the 
Chinese ethnic group than other. They suggest 
that it will be necessary to confirm genotype 
this SNP if sY84 is absent in AZF screening, 
especially for patients in Chinese population.18 
 The sY84 and sY86 are the choice of primers 
for detecting AZFa microdeletion in Caucasian 
population to avoid polymorphism, according to 
EAA guidelines. However, The primers may not 
apply to other ethnic population.18 Our patients 
were consisting of many ethnic groups, such 
as Javanese, Betawi, Batak, Minangkabau, and 
Chinese. We did not note some patients with 
Chinese ethnic group had this partial AZFa 
microdeletion. However, we cannot exclude the 
false positives of AZFa microdeletion caused by 
SNP in our samples because we did not sequence 
the sY84 locus. This can be considered as 
limitation of our study. Therefore, sequencing the 
genomic DNA sequence of sY84 will be needed 
in the future study to exclude this possibility of 
false positives results.
Partial AZFa deletions have been identified 
in some infertility clinics19 not related to the 
pathology of testicular tissue, as suggested 
by Vogt et al.20 Pathological examination of 
testicular tissue shows a varied picture of 
spermatogenetic activity. Testicular tissue biopsy 
performed in patients with partial deletion of 
AZFa often showed hypospermatogenesis, but 
not SCO.11,20 In our study, the testicular histology 
of patients with partial deletion of AZFa was 
found to be similar to that in the literature, not 
demonstrating the SCO syndrome.
Complete deletions of AZFb showed a 
histological form of spermatogenesis arrest at 
primary spermatocyte. This result is consistent 
with the literature that complete deletion shows 
a picture of spermatogenesis arrest in all tubules.
We identified another type of deletion in our 
study, namely, deletion of DBY gene. Previous 
examinations using standard primers for the 
detection of AZFa, b and c regions showed no 
deletions.
To date, the candidate genes that regulate 
spermatogenesis are USP9Y (Ubiquitin-specific 
protease 9y copy) and DBY (Dead Box Y). Both 
of these genes are present in the AZFa region. 
The USP9Y is known to be dominant in the post-
meiotic phase of spermatogenesis.21
Research on the DBY gene protein expression 
inferred that this protein is only found in 
human testicular tissue, and is dominant in the 
spermatogonia and spermatocytes leptoten. This 
fact demonstrates that the gene is functionally 
contributing to the process of cell differentiation 
in the pre meiosis phase. Therefore, DBY can 
now be considered as the primary regulator of 
spermatogenesis genes in the region AZFa.22  The 
DBY genes often deleted in infertile patients 
may lead to severe damage to spermatogenesis, 
ending in a decrease in the number of germ cells 
(spermatogonia), or even the loss of testicular 
germ cells.11 Our study offered comparable 
results to earlier studies that deletion of DBY 
played a specific role in spermatogenesis and 
gave the testicular pathology picture of SCOs.
CONCLUSION
The frequency of partial deletion of AZFa 
was found to be relatively high in our center. 
The type of deletion corresponds to the picture 
of testicular histology.
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